Metformin alone has not shown success in immune thrombocytopenia (ITP) treatments, except when combined with rapamycin. Other drugs like conagiflosen, acarbose, and rapamycin have shown positive outcomes in ITP. Metformin's efficacy remains uncertain, with ongoing research like the TAME study aiming to explore its impact on disease onset in healthy individuals. The discussion on metformin's role in health and longevity is expected to continue in future podcasts.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode